Related references
Note: Only part of the references are listed.Structural dynamics and quantum mechanical aspects of shikonin derivatives as CREBBP bromodomain inhibitors
Sarmistha Mitra et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2018)
Assessing the performance of the MM/PBSA and MM/GBSA methods. 6. Capability to predict protein-protein binding free energies and re-rank binding poses generated by protein-protein docking
Fu Chen et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2016)
Computational investigation of curcumin, a natural polyphenol that inhibits the destabilization and the aggregation of human SOD1 mutant (Ala4Val)
E. Srinivasan et al.
RSC ADVANCES (2016)
Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents
Marwa A. Aziz et al.
SCIENTIFIC REPORTS (2016)
Molecular docking studies of (4Z, 12Z)-cyclopentadeca-4, 12-dienone from Grewia hirsuta with some targets related to type 2 diabetes
Abirami Natarajan et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)
New Ways to Boost Molecular Dynamics Simulations
Elmar Krieger et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2015)
Recent advances in structure-based drug design and virtual screening of VEGFR tyrosine kinase inhibitors
Pui Man Hoi et al.
METHODS (2015)
Lipid14: The Amber Lipid Force Field
Callum J. Dickson et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2014)
Assessing the performance of MM/PBSA and MM/GBSA methods. 4. Accuracies of MM/PBSA and MM/GBSA methodologies evaluated by various simulation protocols using PDBbind data set
Huiyong Sun et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2014)
Assessing the performance of MM/PBSA and MM/GBSA methods. 5. Improved docking performance using high solute dielectric constant MM/GBSA and MM/PBSA rescoring
Huiyong Sun et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2014)
Identification of Natural Compound Inhibitors for Multidrug Efflux Pumps of Escherichia coli and Pseudomonas aeruginosa Using In Silico High-Throughput Virtual Screening and In Vitro Validation
Vasudevan Aparna et al.
PLOS ONE (2014)
Assessing the Performance of MM/PBSA and MM/GBSA Methods. 3. The Impact of Force Fields and Ligand Charge Models
Lei Xu et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2013)
HIM-herbal ingredients in-vivo metabolism database
Hong Kang et al.
JOURNAL OF CHEMINFORMATICS (2013)
In Silico Screening and Molecular Dynamics Simulation of Disease-Associated nsSNP in TYRP1 Gene and Its Structural Consequences in OCA3
Balu Kamaraj et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Development and strategies of VEGFR-2/KDR inhibitors
Lingyi Huang et al.
FUTURE MEDICINAL CHEMISTRY (2012)
Characterization of Domain-Peptide Interaction Interface: Prediction of SH3 Domain-Mediated Protein-Protein Interaction Network in Yeast by Generic Structure-Based Models
Tingjun Hou et al.
JOURNAL OF PROTEOME RESEARCH (2012)
The VSGB 2.0 model: A next generation energy model for high resolution protein structure modeling
Jianing Li et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2011)
Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?
Kristy J. Gotink et al.
ANGIOGENESIS (2010)
Non-ATP Competitive Protein Kinase Inhibitors
L. Garuti et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Anti-angiogenic effects of differentiation-inducing factor-1 involving VEGFR-2 expression inhibition independent of the Wnt/β-catenin signaling pathway
Tatsuya Yoshihara et al.
MOLECULAR CANCER (2010)
Anti-tumor effect of CT-322 as an adnectin inhibitor of vascular endothelial growth factor receptor-2
Roni Mamluk et al.
MABS (2010)
Mechanism of MicroRNA-Target Interaction: Molecular Dynamics Simulations and Thermodynamics Analysis
Yonghua Wang et al.
PLOS COMPUTATIONAL BIOLOGY (2010)
Targeting the tumour vasculature: insights from physiological angiogenesis
Alicia S. Chung et al.
NATURE REVIEWS CANCER (2010)
Perspectives for Cancer Prevention With Natural Compounds
A. R. M. Ruhul Amin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Knowledge based prediction of ligand binding modes and rational inhibitor design for kinase drug discovery
Arup K. Ghose et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Inhibition of Cell Growth and VEGF Expression in Ovarian Cancer Cells by Flavonoids
Haitao Luo et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2008)
Epik:: a software program for pK a prediction and protonation state generation for drug-like molecules
John C. Shelley et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2007)
Mechanisms of adverse effects of anti-VEGF therapy for cancer
T. Kamba et al.
BRITISH JOURNAL OF CANCER (2007)
Molecular basis for sunitinib efficacy and future clinical development
Sandrine Faivre et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Fast empirical pKa prediction by Ewald summation
Elmar Krieger et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2006)
Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism
Alexandr P. Kornev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Peptide inhibitors of protein kinases - discovery, characterisation and use
MA Bogoyevitch et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2005)
Integrated modeling program, applied chemical theory (IMPACT)
JL Banks et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
Mechanistic and structural analysis of a family 31 α-glycosidase and its glycosyl-enzyme intermediate
AL Lovering et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Predictive in silico modeling for hERG channelblockers
MM Aronov
DRUG DISCOVERY TODAY (2005)
The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions
H Takahashi et al.
CLINICAL SCIENCE (2005)
Protein kinase inhibitors: Insights into drug design from structure
MEM Noble et al.
SCIENCE (2004)
Kinomics-structural biology and chemogenomics of kinase inhibitors and targets
M Vieth et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2004)
Development and testing of a general amber force field
JM Wang et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia
H Gerhardt et al.
JOURNAL OF CELL BIOLOGY (2003)
Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation
A Jakalian et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2002)
Toward a pharmacophore for drugs inducing the long QT syndrome:: Insights from a CoMFA study of HERG K+ channel blockers
A Cavalli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Increasing the precision of comparative models with YASARA NOVA - a self-parameterizing force field
E Krieger et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2002)
Prediction of drug solubility from structure
WL Jorgensen et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
By-products of plant food processing as a source of functional compounds - recent developments
A Schieber et al.
TRENDS IN FOOD SCIENCE & TECHNOLOGY (2001)
Pancreas microenvironment promotes VEGF expression and tumor growth: Novel window models for pancreatic tumor angiogenesis and microcirculation
Y Tsuzuki et al.
LABORATORY INVESTIGATION (2001)
Organising evidence on QT prolongation and occurrence of Torsades de Pointes with non-antiarrhythmic drugs:: A call for consensus
F De Ponti et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2001)
HERG K+ channels: friend and foe
JI Vandenberg et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2001)
Prediction of drug solubility from Monte Carlo simulations
WL Jorgensen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2000)
Prediction of properties from simulations: Free energies of solvation in hexadecane, octanol, and water
EM Duffy et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2000)
The Protein Data Bank
HM Berman et al.
NUCLEIC ACIDS RESEARCH (2000)
Share Paper
